Samsung Biologics
207940.KS
#478
Rank
S$63.13 B
Marketcap
S$1,301
Share price
-1.45%
Change (1 day)
20.24%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2026 (TTM): S$32.16

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is S$32.24. In 2025 the company made an earnings per share (EPS) of S$23.89 an increase over its 2024 EPS that were of S$13.38.

EPS history for Samsung Biologics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$32.1634.62%
2025S$23.8978.53%
2024S$13.3811.34%
2023S$12.022.67%
2022S$11.7183.43%
2021S$6.3849.14%
2020S$4.2826.39%
2019S$3.39-12.58%
2018S$3.87-320.64%
2017S-$1.76-46.78%
2016S-$3.30-105.09%
2015S$64.83-1089.67%
2014S-$6.55